CG Oncology Inc banner

Wall St Price Targets

CGON Price Forecast
Based on 15 analysts

+21% Upside
from $74.4 today

CG Oncology Inc (CGON)’s 12-month stock price forecast through November 2027 has a consensus target of $90.27, implying 21% upside. The forecast is based on price targets from 15 Wall Street analysts.

CGON Analyst Rating
Based on 14 analysts

avg. 4.57 of 5
Strong buy
9 64%
Buy
4 29%
Hold
1 7%
Sell
0 0%
Strong sell
0 0%

Analysts rate CGON Strong buy, with 13 of 14 recommending Buy or Strong buy.

CG Oncology Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CGON's stock price target?
Price Target
90.27 USD

According to Wall Street analysts, the average 1-year price target for CGON is 90.27 USD with a low forecast of 80.8 USD and a high forecast of 117.6 USD.

What is the Revenue forecast for CG Oncology Inc?
Projected CAGR
128%

Over the last 3 years, the compound annual growth rate for Revenue has been 177%. The projected CAGR for the next 8 years is 128%.

Back to Top